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Experience with 30 consecutive patients who had a total
of 32 primary cardiac tumors and who underwent two-
dimensional echocardiographic examinations between
January 1977 and June 1983 was reviewed. Most of the
tumors were atrial myxomas (20 left and 4 right), and
30 were identified on echocardiography. Twenty-fivepa-
tients, including 21 of 22 with atrial myxoma, underwent
surgical resection on the basis of the echocardiographic
examination, without preoperative angiocardiography.
When the morphologic characteristics of the left atrial
myxomas were studied statistically in relation to clinical
abnormalities, large tumor size was most closely related
to the number and type of associated clinical and lab-
Two years after its introduction (l) in 1954, echocardiog-
raphy was utilized by Edler and Hertz in the first visual-
ization of an atrial myxoma (Edler, personal communica-
tion; a report ofthis case was not published until 1962 [2]).
In 1959, Effert and Domanig (3) first reported the M-mode
echocardiographic findings in left atrial myxoma. These
early investigators introduced the exciting possibility of non-
invasive diagnosis, and M-mode echocardiography subse-
quently became the method of choice for screening patients
suspected of having a cardiac tumor (4-10). Recently, real-
time two-dimensional echocardiography has allowed more
comprehensive visualization of cardiac anatomy and patho-
logic features including cardiac tumors (1l-20).
The experience reported here includes that of all patients
with a primary tumor of the heart who underwent echocar-
diographic examination between January 1977 (the date of
introduction of two-dimensional echocardiography at the
Mayo Clinic) and June 1983. For completeness, we have
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oratory abnormalities. The single exception was embo-
lization, which correlated with echocardiographic tumor
consistency.
Since the introduction of two-dimensional echocardi-
ography, the yearly incidence of cardiac tumor diagnosis
at this clinic has increased several fold and the incidence
of unexpected intraoperative diagnosis has been very low
(one case). Echocardiography is the method of choice
for clinical diagnosis. It has replaced angiocardiography
for routine preoperative assessment, permits early di-
agnosis of cardiac neoplasms and provides insight into
the pathophysiology of primary cardiac tumors.
(J Am Coil CardioI1985;5:1465-73)
also included information on five patients who had a tumor
discovered incidentally at autopsy and who had not under-
gone an echocardiographic examination. A detailed review
of this large experience from a single institution illustrates
the following: I) the potential impact of two-dimensional
echocardiography on the incidence of tumor diagnosis; 2)
the accuracy of two-dimensional echocardiography for as-
sessment of size, location, point of attachment and tissue
consistency of primary cardiac tumors; 3) the adequacy of
two-dimensional echocardiography for preoperative assess-
ment of most patients; and 4) correlations between certain
echocardiographic morphologic characteristics of atrial
myxomas-most notably size and consistency-and clinical
presentation.
Methods
Patients. We reviewed the history of all patients who
were seen at the Mayo Clinic between January 1977 and
June 1983 (that is, the era of two-dimensional echocardi-
ography) and who were found, either before or after death,
to have one or more primary cardiac tumors (Tables 1 and
2). Thirty-five such patients were identified: 30 had under-
gone two-dimensional echocardiographic examinations and
0735-1097/85/$3.30
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Table 1. Twenty-five Cases of Atrial Myxoma
Age (yr) Tumor Dimensions (cm)/volume (crrr')
Case & Sex Site Attachment Consistency Specimen 2DE
17F LA Orifice, LA Gel. 4.0 x 3.0 x 1.0/8.4 *
appendage
RA Rim FO to IVC Gel. 2.0 x 2.0 x 1.0/2.8 *
20F RA Lat. wall Gel. 5.0 x 4.0 x 3.0/41.9 5.0 x 3.5 x 3.0/36.7
2 63M LA Septum Gel. 10.0 x 9.0 x 3.0/188.5 *
3 38M LA Septum Gel. 3.0 x 3.0 x 3.0/18.8 3.5 x 3.5 x 3.5129.9
4 67F LA Septum Firm 6.0 x 5.0 x 4.0/83.8 Indeterminate
5 25M LA Ant. wall Gel. 3.0 x 3.0 x 3.0/18.8 3.0 x 3.0 x 2.7/17.0
6 44M LA Septum Gel. 5.9 x 4.7 x 2.8/54.2 7.0 x 3.5 x 3.5/59.9
7 49F LA Septum Gel. 5.0 x 5.0 x 1.5/26.2 4.0 x 3.0 x 2.8/23.5
8 62F LA Septum; post. Gel. 7.0 x 5.0 x 4.0/97.7 7.5 x 4.5 x 3.5/82.5
free wall
9 72F LA Post. free wall Firm 6.4 x 4.2 x 3.8/71.3 6.5 x 6.5 x 4.5/132.7
10 54F LA Septum Firm 6.2 x 5.3 x 3.4/78.0 6.5 x 5.0 x 4.5/102.1
11 66F LA Septum Firm 7.5 x 6.5 x 5.0/170.2 7.5 x 6.0 x 6.0/188.5
12 51F LA Septum Gel. 5.0 x 2.7 x 1.9117.9 4.2 x 3.4 x 1.5/14.9
13 67F LA Septum Gel. 4.5 x 3.5 x 2.0/22.0 5.8 x 2.5 x 2.5/25.3
14 72F LA Septum Gel. Indeterminate 2.0 x 1.7 x 1.7/4.0
15 69F LA Ant. wall Gel. 8.0 x 6.0 x 1.5/50.3 8.0 x 4.0 x 4.0/89.4
16 75F LA High lat. wall Gel. 3.9 x 2.4 x 1.9/12.4 4.5 x 3.0 x 2.8/26.4
17 66M LA Septum Firm, calcified 4.7 x 3.1 x 2.6/26.4 3.9 x 3.0 x 2.8122.9
18 60F LA Septum Gel. 2.9 x 2.8 x 2.5/14.2 3.5 x 3.0 x 3.0/22.0
19 66F LA Septum Gel. 2.0 x 1.5 x 1.312.7 2.0 x 1.5 x 1.5/3.1
20 58F LA Septum Gel. 5.9 x 3.0 x 2.4129.7 7.0 x 3.5 x 3.3/56.4
21 78F LA Septum Firm 3.0 x 3.0 x 2.0/12.6 t
22 80M LA Septum Firm 4.0 x 2.8 x 2.8/21.9 t
23 52M LA Septum Gel. 3.0 x 2.5 x 2.0/10.5 t
24 67F RA Between coronary Firm 3.5 x 2.5 x 2.5/15.3 3.5 x 2.5 x 2.0/12.2
sinus and
tricuspid valve
25 54F RA Septum Gel., friable 3.0 x 3.0 x 2.0/12.6 3.5 x 3.5 x 3.5/29.9
thrombus
*Original video records not available; written interpretation and still-frame photographs were used. tNot done. Ant. = anterior; AP = alkaline
phosphatase; AV = atrioventricular; DOE = dyspnea on exertion; ESR = erythrocyte sedimentation rate; F = female; fib. = fibrillation; FO = fossa
5 had not but were discovered to have had a primary tumor
of the heart incidentally at autopsy. Because the primary
objective of this report is to describe our echocardiographic
experience, discussion is focused principally on the 30 pa-
tients who underwent echocardiographic examinations. Some
information on the remaining five patients is included be-
cause it contributes to an understanding of the complete
spectrum of primary cardiac tumors and illustrates the types
of tumors that may elude clinical and echocardiographic
detection. Four patients included in this series have been
described in previous case reports: Case 3 in reference 21,
Case 26 in reference 22 and Cases 31 and 32 in reference
19.
Echocardiography. Original video records of the two-
dimensional echocardiograms were available for review in
all except Cases 1 and 2 (studied in 1977), for which we







Specimen Symptom s (months from AV Valve Laboratory
Case Weight (g) onset to diagno sis) Dysfunction PHT TP Abnormalities
=} Tran sient diplopia (9) NoneNone
18.9 Near syncope (2) ; orthopnea, DOE (2) + Anem ia
2 69 . 1 DOE, edema (24) + + Anem ia, t ESR , t AP
3 7.2 Rash (14 ); transient diplop ia (I ) None
4 40.0 Acute pulmonary edema (1) i gamma globulin
5 Transient cerebral ischemia (72); rash None
(48)
6 45.2 Malais e, myalgia s, arthralgias, + + Anemia, i ESR,
weight loss (10); syncope (5) t (3-g10bulin
7 28.7 Emboli, both legs (3) t ESR
8 74.6 DOE, orthopnea, edema (12) + None
9 53.6 Fever (4); DOE (4) + + + Anemia, i ESR, i AP
10 65 .2 Fever (3); DOE (3) + + Anem ia, t ESR , t AP,
t Qz-globulin
II 136.5 DOE (36) ; paroxysmal atrial fib. (24); + + + t ESR , t a z-globulin
weight loss, myalgias (3)
12 6.3 Rash (4); cerebral infarct (3) Anemia, t ESR, tAP,
t az -globulin
13 10.5 DOE , orthopnea (2) + Anemia, t ESR
14 DOE, orthopnea (6); near syncope (3) None
15 39.8 Mala ise, myalgias (12); DOE (2) + + t ESR, t AP
16 9.3 Syncope (12) + t ESR , t AP
17 16.4 Parox ysmal atrial fib. (360); chest + t ESR
pressure (3 days)
18 10.1 Palpitation (36) + None
19 Cerebral infarct ion (8) t ESR , thrombocytosis
20 13.1 Positional cough (12) ; palpitation (6); + + Anemia, t ESR , t gamma
fever (I ) globulin, i Qz-globulin ,
t ai-globulin
21 Death from myocardial infarction; None
severe coronary atherosclerosis at
autopsy
22 Death from sepsis Anemia (pernicious), t ESR
23 Death from ventricular fib.; severe None
coronary atherosclerosis at autopsy
24 2.8 Paroxy smal atrial fib. (" years" ); None
cerebral infarction (192 )
25 13.1 Recurrent episodes of cough, + t AP
hemoptysis, pleurit ic pain, dyspnea
(252 )
ovali s; Gel. = gelatinous; IVC = inferior vena cava ; LA = left atrium ; Lat. = lateral ; M = male; PHT = pulmonary hypertension; Post . = posterior;
RA = right atrium; TP = tumor plop; 2DE = two-d imensional echocardiography; t = high ; + = present; - = absent.
used written interpretationsand still-frame photographs. These
two patients were studied with a 30° mechanical sector scan-
ner; for the other patients , wide-angle sector scanners were
used. The review of all two-dimensional echocardiograms
for tumor location, size, point of attachment, mobility and
other morphologic characteristics was performed without
knowledge of the surgical or pathologic data. Using spec-
imens and surgical records, we assessed the accuracy of the
two-dimensional echocardiographic descriptions. Various
clinical and laboratory findings were reviewed with partic-
ular attention to correlations with morphologic character-
istics of the tumors. For the left atrial myxomas, a statistical
analysis of the relations of tumor volume and consistency
to various clinical and laboratory variables was performed.
Because the distribution of volumes was markedly skewed,
nonparametric methods were used. The relations of volume
to discrete clinical and laboratory variables were investi-
gated with Wilcoxon's rank-sum test. The relations to con-




Table 2. Ten Cases of Tumors Other Th an Myxoma
Age (yr) Size
Case &Sex Type Location Specimen (em) 2DE (em) Presentation
26 2'I2F Myxosarcoma LA 3.5 x 2.5 x 2.0 1.8 x 1.8 x 1.8 Cerebral infarction
27 31M Angiosarcoma RA 7.5 x 6.0 x 2.5 7.5 x 6.5 x 3.0 Cardiac tamponade
28 32/3M Fibroma LV 7.0 x 4.0 x 3.5 6.0 x 3.5 x 3.5 Asymptomatic; abnormal chest X-ray film
29 3V2F Fibroma VS 8.0 x 5.0 x 5.0 6.5 x 5.0' x 3.5 Asymptomatic; abnormal chest X-ray film
30 25M Fibroma LV 6.0 x 4.0 x 4.0 6.0 x 4.0 x 4.0 Palpitation; atypical chest pain
31 55F Papillary MV 1.0 x 1.0 x 0.8 1.5 x 1.5 x 1.0 Asymptomatic; murmur
fibroelastoma of mitral valve prolapse
32 4lM Papillary AV I.5 x 1.0 x 1.0 I.5 x 1.0 x 1.0 Atypical chest pain
fibroelastoma
33 65F Papillary TV 0.5 x 0.5 x 0.5 * Incidental finding at autopsy
fibroelastoma
34 35M Papillary AV 0.7 x 0.2 x 0.2 t Incidental finding at autopsy
fibroelastoma
35 59F Papillary PV 1.0 x 1.0 x 1.0 t Incidental finding at autopsy
fibroelastoma
*Tumor not seen; t not done. AV = aortic valve; LV = left ventricle; MV = mitral valve; PV = pulmonary valve; TV = tricuspid valve; VS =
ventricular septum; other abbreviations as in Table I.
tinuous variables were investigated by using Spearman 's
rank correlations.
Tumor dimensions . To facilitate comparison of the ac-
tual size of the atrial myxoma specimens with the size de-
termined echocardiographically , approximate volumes were
determined . For the surgical specimens, this volume was
computed by measuring the maximal dimensions along three
axes and applying the volume formula for a prolate ellipsoid.
Echocardiographic tumor dimensions were measured by de-
termining the length (basal-apical or Y axis) and width (an-
terior-posterior or Z axis) from a parasternal , apical or sub-
costal long-axis view and the third dimension (right-left or
X axis) from a corresponding short-axis projection. The
" echocardiographic volume" of each tumor was approxi-
mated by using these measured dimensions in the formula
for a prolate ellipsoid. For the highly deformable atrial tu-
mors, measurements were performed in diastole .
Results
Spectrum of cardiac tumors and incidence of diag-
nosis (Tables 1 to 3). The 30 patients who underwent echo-
cardiographic examination had a total of 32 primary cardiac
tumors. In Case 1 there were three atrial myxomas: initial
bilateral atrial myxomas and later a recurrent second right
atrial myxoma. Thirty (94%) of these 32 tumors were iden-
tified by two-dimensional echocardiography. The excep-
tions were a small sessile right atrial myxoma found inci-
dentally at operation for a large left atrial myxoma (Case
I) and a small tricuspid valve papillary fibroelastoma that








































*Noechocardiographic examinationin these five patients; tincludes one patient(Case I) with bilateralatrial
myxomas and a later second right atrial myxoma.





was not seen on an antemortem echocardiographic exami-
nation but was found incidentally at autopsy (Case 33) . For
the period of this study the mean rate of preoperative rec-
ognition was 3.5 atrial myxomas per year. The mean rate
of preoperative diagnosis of all primary cardiac neoplasms
was 4.6 tumors per year.
A review of patient records for the 9 years before the
introduction of two-dimensional echocardiography at the
Mayo Clinic (that is, the M-mode era from 1968 to 1976)
revealed that preoperative diagnosis of atrial myxomas av-
eraged 1.6 tumors per year (23) . In the 14 years between
1957 and 1971 (that is, before routine clinical use of echo-
cardiography), 15 primary cardiac tumors (13 atrial myxo-
mas and 2 ventricular fibromas) were diagnosed preopera-
tively (approximately I tumor per year) (24).
Five additional tumors were found incidentally among
the 5,227 autopsies performed during the study period: three
left atrial myxomas and two papillary fibroelastomas . None
of these five patients had undergone an echocardiographic
examination .
Tumor characteristics. Location/attachment. The sites
of attachment for the 20 left atrial myxomas are shown in
Figure 1. Fourteen (70%) were attached to the atrial septum .
The point of attachment was not discernible by echocardi-
ography in only four cases (20%): in Case 4 because of
poor image quality and in Cases 9, 10 and 11 because the
tumors were large and remained in intimate contact with
large portions of the left atrial endocardium throughout the
cardiac cycle. Point of attachment was noted and confirmed
at surgery in each case (Fig . I ) . The location, extent and
site of attachment for the three visualized right atrial myxo-
mas and for the six nonmyxoma tumors were correctly dis-
cerned by two-dimensional echocardiography (Tables 1 and
2).
Tumor consistency (Table I) . Fifteen left atrial myxomas
and three right atrial myxomas were deformable and jelly-
like in echocardiographic appearance (Fig. 2). Five left atrial
myxomas and one right atrial myxoma were nondeformable
and firm in appearance (Fig . 3 and 4). On inspect ion at
operation, the deformable myxomas were found to be ge-
latinous, papillary and friable, whereas the nondeformable
tumors were smooth , firm and nonfriable (Fig . 3) .
Echolucent areas within the tumors were visualized in
five left atrial myxomas and one right atrial myxoma (Fig .
3 and 4), and corresponding areas of hemorrhage or necrosis
were present in the gross specimens in four. Two of these
myxomas were papillary, friable masses that had no cor-
responding pathologic abnormality to account for the echo-
lucency. Only one myxoma was calcified and this charac-
teristic was correctly identified echocardiographically .
The thin stalk and fronded head of each papillary ft-
broelastoma gave a characteristic echocardiographic ap-
pearance suggestive of a small "pompon" attached to the
valve leaflet (19). The firm, intramyocardial fibromas were
Figure 1. Parasternal short-axis view with the attachment points
of the 20 left atrial myxomas and 4 right atrial myxomas studied
echocardiographically and confirmed at surgery . Fourteen of the
left atrial myxomas were attached to the atrial septum as indicated
by X (Cases 2 to 4, 6, 7, 10 to 14 and 17 to 20). The locations
of the remaining 10 myxomas are denoted by numbers which
correspond to the case numbers in Table I (see text for detailed
descriptions of points of attachment) . Identification of point of
attachment for large tumors (Cases 4, 9, 10 and II) was not
possible by echocardiography. A = anterior ; Ao = aorta; L =
left; LA = left atrium; LAA = left atrial appendage; P = pos-
terior; R = right; RA = right atrium; RVO = right ventricular
outflow tract (the atrial septum is shown by the broken line) .
nonmobile and of uniform consistency echocardiographi-
cally. The gelatinous myxosarcoma was deformable , mobile
and jelly-like.
Preoperative two-dimensional echocardiography. All
29 patients whose tumors were diagnosed during life under-
went surgical resections . Of these, only the two children
Figure 2. Case 16. Parasternal long-axis view during diastole,
showing a mobile left atrial myxoma (T) that did not enter the
mitral orifice because of its attachment high in the left atrium. The
M-mode echocardiogram at the mitral valve level was normal. I
= inferior ; LV = left ventricle; MV = mitral valve; RV = right
ventricle; S = superior ; VS = ventricular septum; other abbre-
viations as in Figure I .
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Figure 3. Case 9. A, Parasternal long-axis view of large, firm
left atrial myxoma remaining impacted in left atrium during di-
astole, which prevented determination of point of attachment. The
tumor (T) contains a central region of echolucency (arrowheads)
that corresponds to an area of liquefaction. B, Cut section of gross
specimen, showing large area of liquefaction(arrow). This myxoma
was firm and had a smooth surface. Abbreviations as in Figures
I and 2.
with ventricular fibromas (Cases 28 and 29) underwent di-
agnostic preoperative angiography at the Mayo Clinic. One
patient with a left atrial myxoma (Case 17) had preoperative
coronary and left ventricular angiography for assessment of
coronary artery disease. In all three of these cases, the
diagnosis of primary cardiac tumor had been made by echo-
cardiography before catheterization. Three additional pa-
tients had cardiac catheterization and angiography elsewhere
before referral. In Case 15, a levophase pulmonary angio-
gram was obtained to confirm the presence of a left atrial
myxoma visualized by M-mode echocardiography. In Case
25, two right heart catheterizations with pulmonary angi-
ography (2 and 6 months before referral) showed multiple
Figure 4. Case 17. Apical four chamber view during diastole,
showing an immobile left atrial myxoma that failed to prolapse
through the mitral valve (MV) because of its short pedicle and
firm consistency. This tumor (T) was calcified and had an area of
echolucency (E) that corresponded to a region of tumor necrosis.
Abbreviations as in Figures I and 2.
pulmonary emboli. The large right atrial myxoma, subse-
quently diagnosed by two-dimensional echocardiography,
was not recognized in either study. In Case 32 the patient
had been referred because of a suspected aortic valve mass
observedat angiographyfor suspectedcoronaryarterydisease.
Twenty-jive (86%) ofthe 29 patients underwent operation
on the basis of two-dimensional echocardiography. In all
but one patient (Case 15) with atrial myxomas, two-dimen-
sional echocardiography without angiography or other im-
aging techniques was used for preoperative assessment. There
were no surgically related deaths. Preoperative morbidity
included hemiparesis presumably due to intraoperative tu-
mor embolization (Case 2) and postoperative complete heart
block in four patients with a left atrial myxoma. The heart
block was transient in three patients and permanent in one
who required a permanent pacemaker.
Clinical and laboratory correlations. We examined the
relation between morphologic characteristics of the tumors
and the clinical and laboratory findings. This comparison
was most applicable to left atrial myxomas, which are known
to be associated with protean clinical and laboratory
manifestations.
Constitutional symptoms. Six (30%) of 20 patients with
left atrial myxoma had constitutional symptoms such as
myalgias/arthralgias, fever, sweats and weight loss. Only
tumor size appeared related to these findings. For those
tumors associated with these findings, the mean calculated
volume was 75.6 em" (range 29.7 to 170.2) compared with





38.7 crrr' (range 2.7 to 188.5) for all of the others. The
tendency for large tumors to produce constitutional symp-
toms was statistically significant (p < 0.006). Constitutional
symptoms were not observed among patients with a right
atrial myxoma or nonmyxoma cardiac tumor.
Congestive heart failure and syncope. Symptoms of heart
failure, in the presence of adequate left ventricular function,
were present in II (55%) of 20 patients with a left atrial
myxoma (Table 1), and syncope (or near syncope) was
described by 3 patients (15%). The tumors associated with
these symptoms were usually large, averaging 71.8 em"
(range 4.0 to 188.5) compared with 16.7 em" (range 2.7 to
26.4) for the eight other patients. The relation of tumor
volume to the presence of either congestive heart failure or
syncope was statistically significant (p < 0.02). All but one
(Case 16) of the left atrial myxomas associated with these
symptoms either prolapsed into the mitral valve orifice or
were so large that they obliterated the left atrial cavity.
Of the four right atrial myxomas, only the large recurrent
tumor in Case I was associated with syncope and symptoms
of right heart failure. Loss of consciousness was the pre-
senting symptom in the patient with myxosarcoma (Case
26), but this was due to massive cerebral embolization.
Congestive heart failure and syncope were not seen among
those patients with ventricular fibromas or papillary fibro-
e1astomas. In Case 27 with right atrial angiosarcoma, the
patient presented with life-threatening cardiac tamponade
caused by a large, bloody pericardial effusion.
Embolization. Six patients (30%) with a left atrial myxoma
had clinical evidence of embolization: large emboli to the
lower limbs in one case and cerebrovascular events in five
others. Three of the latter five patients also had maculo-
papular rashes on the limbs, thought to be caused by showers
of small emboli. Tumors associated with embolization tended
to be smaller (mean volume 15.5 em"; range 2.7 to 26.2)
compared with the others (mean 64.5 ern"; range 4.0 to
188.5) and all were gelatinous in consistency. The inverse
relation between tumor size and embolization was statisti-
cally significant (p < 0.03). The association of embolization
with gelatinous tumors was not statistically significant, pos-
sibly because of the small number of firm tumors.
Patient 25 had angiographic evidence of recurrent pul-
monary emboli. This tumor was highly deformable and ge-
latinous and, at operation, the myxoma was found to be
encased in friable thrombus that was thought to be the source
of the chronic embolization and resultant pulmonary hy-
pertension. Clinically, none of the three other right atrial
myxomas embolized. A child with a gelatinous left atrial
myxosarcoma (Case 26) was the only patient with a non-
myxoma tumor to have emboli.
Auscultation. Of the 20 patients with left atrial myxoma,
10 (50%) had auscultatory findings suggesting mitral valve
stenosis or insufficiency, 3 (15%) had signs of pulmonary
hypertension and 8 (40%) had an early diastolic tumor plop
(Table I). The tumors associated with auscultatory findings
of mitral valve dysfunction, pulmonary hypertension or tu-
mor plop usually were larger, with a mean volume of 67.9
em" (range 12.4 to 188.5) compared with 22.6 em? (range
2.7 to 83.8). This association was also statistically signif-
icant (p < 0.03). All tumors associated with pulmonary
hypertension were firm and impacted in the left atrium.
Two right atrial myxomas produced signs of tricuspid
valve insufficiency and stenosis (Table 1). Both were large
and prolapsed into the tricuspid valve orifice in diastole.
One papillary fibroelastoma (Case 31) was associated with
a systolic click and murmur characteristic of mitral valve
prolapse, which was observed on the echocardiogram. A
young man with a right atrial angiosarcoma (Case 27) pre-
sented with a pericardial friction rub and third heart sound
accompanying the other physical signs of tamponade. The
remaining tumors were silent or were associated with non-
specific ejection-type murmurs.
Blood chemistry. Hematologic and serologic abnormal-
ities among patients with a left atrial myxoma are given in
Table I. One or more of the markers classically associated
with left atrial myxoma (anemia, increased erythrocyte sed-
imentation rate and increased gamma globulin concentra-
tion) occurred in 14 (70%) of the 20 patients: anemia in 7
(35%, mean hemoglobin 10.3 g/dl); increased erythrocyte
sedimentation rate, 13 (68%) of the 19 patients in whom it
was measured (mean 83.2 mm in I hour, Westergren) and
polyclonal increase in gamma globulin in 2 (14%) of 14
patients in whom serum protein electrophoresis was per-
formed. Other observed laboratory abnormalities included
increased alpha.sglobulin (1 case); increased alpha--glob-
ulin (4 cases); increased beta-globulin (1 case); increased
aspartate aminotransferase (1 case); increased alkaline phos-
phatase (6 cases); increased total and direct bilirubin (2
cases) and thrombocytosis (1 case). The increases in alphal-
globulin, alpha--globulin, beta-globulin and alkaline phos-
phatase always occurred in association with an increased
erythrocyte sedimentation rate.
The left atrial myxomas associated with the three classic
laboratory abnormalities (anemia, increased erythrocyte
sedimentation rate and increased gamma globulin) on the
average were larger (mean 59.5 ern"; range 2.7 to 188.5)
than the tumors not associated with these abnormalities (mean
27.0 crrr'; range 4.0 to 97.7). This association was statis-
tically significant (p < 0.03). The relations between volume
and the individual continuous variables of sedimentation
rate, hemoglobin and gamma globulin did not achieve sta-
tistical significance. No other morphologic characteristics
were found to be related to these laboratory abnormalities.
The only laboratory abnormality observed among pa-
tients with right atrial myxoma was a mildly increased al-
kaline phosphatase value in one case. Leukocytosis was
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present in Case 26 (myxosarcoma), and increased aspartate
aminotransferase and anemia were present in Case 27 (an-
giosarcoma). No laboratory abnormalities were observed in
the other cases of nonmyxoma tumors.
Discussion
Incidence. At our institution, the average number of
primary cardiac tumors diagnosed preoperatively has in-
creased significantly during the echocardiographic era (1968
to 1983), the most substantial increase occurring since the
introduction of two-dimensional echocardiography in 1977.
The most important practices contributing to this trend ap-
pear to be the widespread use of two-dimensional echo-
cardiography to exclude a cardiac source for emboli and the
acceptance of two-dimensional echocardiography as the
method of choice to define cardiac anatomy in the presence
of auscultatory abnormalities or symptoms thought to be
related to cardiac dysfunction. The former trend facilitates
identification of smaller tumors associated with few abnor-
malities other than emboli, and the latter leads to discovery
of larger tumors misdiagnosed clinically. The increased in-
cidence of diagnosis is far in excess of the increase in our
patient population and cannot be attributed to more frequent
clinical diagnosis: of the 20 patients with a left atrial myxoma,
only 3 were referred for echocardiography with a presump-
tive diagnosis of left atrial tumor.
The review of autopsy records illustrates the persistence
of a small number of unsuspected and undiagnosed primary
cardiac tumors, including atrial myxomas, among our pa-
tient population. Although all three patients with a left atrial
myxoma found at autopsy had received routine medical care
at this institution, the presence of the tumor was unsus-
pected. Diagnosis of a small atrial myxoma that has not
embolized, such as that found in Cases 21 to 23, is usually
serendipitous and requires considerable acuity in interpret-
ing a very few nonspecific findings.
Types of tumor. Among the 30 patients studied echo-
cardiographically, various benign and malignant neoplasms
were observed. The distribution of tumor types was similar
to that reported in other clinical series (23-29). The most
common was atrial myxoma (75%, 24 tumors); 20 (83%)
of these 24 arose in the left atrium. Of the 32 tumors, 30
(94%) were visualized by two-dimensional echocardiog-
raphy. This experience suggests that the majority of primary
cardiac neoplasms may be diagnosed by careful two-di-
mensional echocardiographic examination and supports the
use of this technique as the standard for clinical diagnosis.
Clinical presentation correlated with echocardio-
graphic findings. Two-dimensional echocardiography per-
mits accurate determination of tumor size, point of attach-
ment, mobility and consistency. In patients with left atrial
myxoma, larger tumor size appears to be a significant de-
terminant of clinical presentation in each of the following
categories of findings: 1) constitutional symptoms (myal-
gias, arthralgias, night sweats and weight loss); 2) obstruc-
tive symptoms (congestive heart failure and syncope); 3)
hematologic or serologic abnormalities (anemia, increased
erythrocyte sedimentation rate and increased gamma glob-
ulin level); and 4) auscultatory abnormalities suggesting
mitral valve dysfunction, pulmonary hypertension or tumor
plop. The notable exception was embolization, which was
inversely related to tumor size but was directly related to
tumor consistency. Only the highly deformable, mobile tu-
mors found pathologically to be friable and gelatinous had
embolized, as was also observed by Larrieu et al. (29).
These correlations pose something of a dilemma in selecting
patients with stroke or peripheral emboli for echocardio-
graphic screening because associated clinical abnormalities
that might suggest the presence of a myxoma and be an
indication for echocardiographic examination were few or
absent in the patients with a small myxoma.
Rahilly and Nanda (30) suggested that visualization of
an echo lucent region in a left atrial mass might be useful
in distinguishing a myxoma from thrombus or vegetation.
Our experience indicates that echolucencies, presumably
caused by tumor infarction or hemorrhage, are uncommon
and insensitive markers, but this study does not permit eval-
uation of the specificity of this observation.
Surgical treatment. Several authors (18,23,27,29,31)
have suggested that operation for atrial myxoma might be
performed safely on the basis of two-dimensional echo-
cardiography alone. The present experience strongly sup-
ports this contention not only for atrial myxomas but for
some other primary tumors of the heart as well. In our patient
group there were no surgically related deaths. Postoperative
morbidity was low. On the basis of this experience, two-
dimensional echocardiography has essentially supplanted
angiography in preoperative assessment of these patients in
our practice.
Conclusion. Two-dimensional echocardiography is a
powerful technique for diagnosing primary tumors of the
heart. For most tumors, operation may be undertaken safely
without resorting to other imaging procedures. The ready
availability of two-dimensional echocardiography has led to
an increased incidence of tumor detection and resection. In
our experience, atrial myxoma is by far the most common
primary tumor observed. Primary malignancies are rare. In
patients with a left atrial myxoma, clinical manifestations
(except for embolization) are more likely to occur with a
large tumor. Embolization seems most closely related to the
friability of the tumor.
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